HRP20160552T1 - Derivati polimiksina i njihove uporabe - Google Patents

Derivati polimiksina i njihove uporabe Download PDF

Info

Publication number
HRP20160552T1
HRP20160552T1 HRP20160552TT HRP20160552T HRP20160552T1 HR P20160552 T1 HRP20160552 T1 HR P20160552T1 HR P20160552T T HRP20160552T T HR P20160552TT HR P20160552 T HRP20160552 T HR P20160552T HR P20160552 T1 HRP20160552 T1 HR P20160552T1
Authority
HR
Croatia
Prior art keywords
seq
group
derivative
polymyxin
derivatives
Prior art date
Application number
HRP20160552TT
Other languages
English (en)
Croatian (hr)
Inventor
Martti Vaara
Timo Vaara
Original Assignee
Northern Antibiotics Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Northern Antibiotics Oy filed Critical Northern Antibiotics Oy
Publication of HRP20160552T1 publication Critical patent/HRP20160552T1/hr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/60—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation occurring through the 4-amino group of 2,4-diamino-butanoic acid
    • C07K7/62—Polymyxins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
HRP20160552TT 2006-08-11 2007-08-10 Derivati polimiksina i njihove uporabe HRP20160552T1 (hr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US83742606P 2006-08-11 2006-08-11
DKPA200601055 2006-08-11
EP07803704.1A EP2057185B1 (en) 2006-08-11 2007-08-10 Polymyxin derivatives and uses thereof
PCT/FI2007/050441 WO2008017734A1 (en) 2006-08-11 2007-08-10 Polymyxin derivatives and uses thereof

Publications (1)

Publication Number Publication Date
HRP20160552T1 true HRP20160552T1 (hr) 2016-07-15

Family

ID=39032653

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20160552TT HRP20160552T1 (hr) 2006-08-11 2007-08-10 Derivati polimiksina i njihove uporabe

Country Status (21)

Country Link
EP (2) EP2057185B1 (cg-RX-API-DMAC7.html)
JP (1) JP5226685B2 (cg-RX-API-DMAC7.html)
KR (2) KR101502453B1 (cg-RX-API-DMAC7.html)
CN (2) CN103059106B (cg-RX-API-DMAC7.html)
AU (1) AU2007283514B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0715095B8 (cg-RX-API-DMAC7.html)
CA (1) CA2694289C (cg-RX-API-DMAC7.html)
CY (1) CY1117848T1 (cg-RX-API-DMAC7.html)
DK (1) DK2057185T3 (cg-RX-API-DMAC7.html)
ES (1) ES2575521T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20160552T1 (cg-RX-API-DMAC7.html)
HU (1) HUE028271T2 (cg-RX-API-DMAC7.html)
IL (2) IL196693B (cg-RX-API-DMAC7.html)
MX (1) MX2009001398A (cg-RX-API-DMAC7.html)
NO (1) NO341982B1 (cg-RX-API-DMAC7.html)
NZ (1) NZ575421A (cg-RX-API-DMAC7.html)
PL (1) PL2057185T3 (cg-RX-API-DMAC7.html)
PT (1) PT2057185E (cg-RX-API-DMAC7.html)
RU (1) RU2455311C2 (cg-RX-API-DMAC7.html)
SI (1) SI2057185T1 (cg-RX-API-DMAC7.html)
WO (1) WO2008017734A1 (cg-RX-API-DMAC7.html)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060004185A1 (en) 2004-07-01 2006-01-05 Leese Richard A Peptide antibiotics and peptide intermediates for their prepartion
FI20085469A0 (fi) * 2008-02-08 2008-05-16 Northern Antibiotics Oy Polymyksiinijohdannaiset, joissa on lyhyt rasvahappohäntä, ja niiden käyttöjä
US8343912B2 (en) 2008-12-23 2013-01-01 Biosource Pharm, Inc. Antibiotic compositions for the treatment of gram negative infections
US8415307B1 (en) 2010-06-23 2013-04-09 Biosource Pharm, Inc. Antibiotic compositions for the treatment of gram negative infections
WO2012051663A1 (en) * 2010-10-21 2012-04-26 Monash University Antimicrobial compounds
BR112014012016A2 (pt) * 2011-11-18 2017-05-16 Cantab Anti-Infectives Ltd compostos
PL2999711T3 (pl) * 2013-05-22 2022-09-26 Spero Therapeutics, Inc. Pochodne polimyksyny i ich zastosowanie w terapii skojarzonej razem z różnymi antybiotykami
DK3116897T3 (da) * 2014-03-11 2022-03-28 Spero Therapeutics Inc Polymyxinderivater og deres anvendelse i kombinationsterapi sammen med forskellige antibiotika
KR101664106B1 (ko) 2014-09-11 2016-10-10 한국화학연구원 폴리믹신 b 화합물을 포함하는 심혈관 질환의 예방 및 치료용 약학적 조성물
CN107108699A (zh) * 2014-11-26 2017-08-29 新药物许可控股有限公司 化合物
CA2970546A1 (en) 2014-12-16 2016-06-23 Micurx Pharmaceuticals, Inc. Antimicrobial polymyxins for treatment of bacterial infections
WO2016097754A1 (en) * 2014-12-18 2016-06-23 Helperby Therapeutics Limited Novel combination and use
FI126143B (en) * 2015-01-15 2016-07-15 Northern Antibiotics Oy Polymyxine derivative and its uses
US9763996B2 (en) 2015-01-16 2017-09-19 Northern Antibiotics, Ltd. Polymyxin derivative and uses thereof
CN104672307B (zh) * 2015-03-23 2017-09-29 吉林大学 一种提高阳离子短肽抗菌性和稳定性的方法
EP3072956A1 (en) * 2015-03-25 2016-09-28 Université de Fribourg Selective culture medium for polymyxin-resistant, gram-negative bacteria
FR3036406B1 (fr) 2015-05-20 2019-07-19 Biomerieux Identification des bacteries resistantes aux carbapenemes par impermeabilite membranaire
WO2017083859A1 (en) * 2015-11-12 2017-05-18 The Trustees Of Columbia University In The City Of New York Rational drug design targeting resistant gram-negative bacterial infections to polymyxin-class antibiotics
WO2017189868A1 (en) * 2016-04-27 2017-11-02 Spero Opco Serine replacement polymyxin analogues useful as antibiotic potentiators
WO2017189866A1 (en) * 2016-04-27 2017-11-02 Spero Opco Polymyxin analogs useful as antibiotic potentiators
GB201703898D0 (en) 2017-03-10 2017-04-26 Helperby Therapeautics Ltd Method
GB201704620D0 (en) 2017-03-23 2017-05-10 Helperby Therapeautics Ltd Combinations
CN111527100A (zh) * 2017-11-02 2020-08-11 昆士兰大学 肽类抗生素
EP3560489A1 (en) * 2018-04-27 2019-10-30 European Molecular Biology Laboratory Pharmaceutical compositions for prevention and/or treatment of infections and antibacterial-induced dysfunctions
BR112020026663A2 (pt) 2018-06-25 2021-03-23 Spero Therapeutics, Inc. Compostos
WO2020018173A1 (en) * 2018-07-19 2020-01-23 Northeastern University Compounds with antimicrobial properties
CN110179967A (zh) * 2019-05-28 2019-08-30 中国医药集团总公司四川抗菌素工业研究所 多粘菌素母核和一种抗生素的组合物及其应用
IT201900025414A1 (it) * 2019-12-23 2021-06-23 Univ Bologna Alma Mater Studiorum Composto per il trattamento della sindrome emolitico uremica
WO2021150792A1 (en) 2020-01-21 2021-07-29 Micurx Pharmaceuticals, Inc. Novel compounds and composition for targeted therapy of kidney-associated cancers
CN118028504B (zh) * 2022-08-30 2024-08-02 四川大学华西医院 一类phoQ基因突变体、应用及其验证方法
WO2024123712A1 (en) * 2022-12-04 2024-06-13 Genentech, Inc. Analysis of candidate cytotoxic compositions
CN120399010B (zh) * 2025-07-01 2025-09-12 杭州肽佳生物科技有限公司 抗生素多粘菌素的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3450687A (en) 1966-02-24 1969-06-17 Pfizer & Co C Lower alkanoyl esters of polymyxin antibiotics
JPS4915537B1 (cg-RX-API-DMAC7.html) 1970-03-25 1974-04-16
BE754411A (fr) 1969-08-05 1971-02-04 Rhone Poulenc Sa Cyclopeptides derives des polymyxines et leur
GB2128617A (en) 1982-10-06 1984-05-02 Martti Vaara Polypeptides for use in antibacterial therapy
US20040063754A1 (en) * 2000-11-20 2004-04-01 Hisashi Takahashi Dehalogeno compounds
CA2444637A1 (en) 2001-01-16 2002-07-18 Ramot University Authority For Applied Research & Industrial Development Ltd. Hybrid peptides for treatment of bacteremia and septicemia
EP1340506B1 (en) * 2002-03-01 2006-12-27 CHIESI FARMACEUTICI S.p.A. Compositions comprising pulmonary surfactants and a polymyxin having improved surface properties
US20060004185A1 (en) * 2004-07-01 2006-01-05 Leese Richard A Peptide antibiotics and peptide intermediates for their prepartion

Also Published As

Publication number Publication date
JP5226685B2 (ja) 2013-07-03
PT2057185E (pt) 2016-06-17
BRPI0715095A2 (pt) 2013-10-15
NO341982B1 (no) 2018-03-05
HUE028271T2 (en) 2016-12-28
NZ575421A (en) 2011-11-25
CA2694289A1 (en) 2008-02-14
RU2455311C2 (ru) 2012-07-10
CA2694289C (en) 2015-04-07
EP3078672A1 (en) 2016-10-12
CN101501063B (zh) 2014-03-12
KR101502453B1 (ko) 2015-03-24
WO2008017734A8 (en) 2009-07-30
EP2057185B1 (en) 2016-05-11
IL220270A0 (en) 2012-07-31
NO20090674L (no) 2009-05-08
MX2009001398A (es) 2009-02-17
BRPI0715095B1 (pt) 2018-08-07
JP2010500331A (ja) 2010-01-07
CN103059106A (zh) 2013-04-24
CY1117848T1 (el) 2017-05-17
SI2057185T1 (sl) 2016-10-28
PL2057185T3 (pl) 2016-09-30
EP2057185A1 (en) 2009-05-13
IL196693B (en) 2018-01-31
CN101501063A (zh) 2009-08-05
IL196693A0 (en) 2009-11-18
AU2007283514B2 (en) 2012-09-06
KR20090045932A (ko) 2009-05-08
WO2008017734A1 (en) 2008-02-14
KR20150008198A (ko) 2015-01-21
DK2057185T3 (en) 2016-06-13
BRPI0715095B8 (pt) 2021-05-25
EP2057185A4 (en) 2009-08-19
ES2575521T3 (es) 2016-06-29
RU2009107857A (ru) 2010-09-20
CN103059106B (zh) 2015-01-14
AU2007283514A1 (en) 2008-02-14

Similar Documents

Publication Publication Date Title
HRP20160552T1 (hr) Derivati polimiksina i njihove uporabe
Niccolai et al. The renewed challenge of antibacterial chemotherapy
Rayner et al. Siderophore conjugates to combat antibiotic-resistant bacteria
Moellering Jr Discovering new antimicrobial agents
Devasahayam et al. Newer antibacterial drugs for a new century
MacDougall et al. Protein synthesis inhibitors and miscellaneous antibacterial agents
Mohr History of antibiotics research
HRP20180180T1 (hr) Derivat polimiksina i njegova uporaba
US9919029B2 (en) Methods and pharmaceutical compositions for the treatment of bacterial infections
MX2010008674A (es) Derivados de polimixina con terminal de acido graso corta y usos de los msmos.
Patil et al. Bactericidal and Bacteriostatic
Lewis et al. Antibacterial agents
JP6480870B2 (ja) 細菌感染を処置するための組成物および方法
US20210260101A1 (en) Potentiated antibiotic compositions and methods of use for treating bacterial infections and biofilms
Kaur et al. Discovery and development of antibacterial agents: Fortuitous and designed
Strahilevitz et al. Novel agents for resistant Gram-positive infections—a review
KR101850265B1 (ko) 항균제 및 타조박탐을 포함하는 조성물
Wach et al. Reduce to the maximum: truncated natural products as powerful modulators of biological processes
Tanaka et al. Synthesis and in vitro evaluation of bisphosphonated glycopeptide prodrugs for the treatment of osteomyelitis
WO2016027262A1 (en) Antibacterial sideromycins
Dyson et al. War and peace: Exploring microbial defence systems as a source of new antimicrobial therapies
AU2013301576B2 (en) Combinations with a backbone-cyclized peptide
Mushtaq et al. Mechanisms of action of Antibacterial agents
AU2015339039A1 (en) Synergistic compositions for treating microbial infections
Dan et al. Chronic high-level multidrug-resistant Campylobacter coli enterocolitis in an agammaglobulinemia patient: oral gentamicin efficacy